Vincent Vultaggio

PAO and PFO, Zentalis Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Feb 10, 2026

Companies

Zentalis Pharmaceuticals, Inc.PAO and PFO −$0.1M

Trades

ZNTL Sold 6,894 shares at $2.42 · planned $0.0M Feb 10

ZNTL Sold 3,379 shares at $2.39 · planned $0.0M Feb 9

ZNTL Sold 29,951 shares at $2.43 · planned $0.1M Feb 6

ZNTL Sold 556 shares at $2.52 · planned $0.0M Feb 3

ZNTL Sold 2,540 shares at $2.55 · planned $0.0M Feb 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.